Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line

Area of Science:

• Molecular Biology
• Cancer Research
• Genomics

Background:

• Chemotherapy resistance is a major cause of cancer treatment failure.
• Cell lines serve as crucial models for investigating the mechanisms underlying drug resistance.
• Understanding the genetic basis of multidrug resistance (MDR) is vital for developing effective cancer therapies.

Purpose of the Study:

• To analyze the transcriptional profiles of two multidrug resistant (MDR) cell lines (Lucena 1 and FEPS) derived from the drug-sensitive K562 cell line.
• To identify differentially expressed genes (DEGs) associated with multidrug resistance.
• To investigate the role of specific pathways, such as the NOTCH pathway, and genes like ABCB1 in MDR.

Main Methods:

• Utilized microarray analysis to compare gene expression patterns.
• Derived and characterized two MDR cell lines (Lucena 1 and FEPS) from a parental drug-sensitive K562 cell line.
• Quantified gene expression levels and analyzed promoter methylation status of key genes.

Main Results:

• Identified significant numbers of differentially expressed genes (DEGs) between sensitive and resistant cell lines: 130 (K562 vs. Lucena 1), 1932 (K562 vs. FEPS), and 1211 (Lucena 1 vs. FEPS).
• The NOTCH pathway was notably affected in the FEPS cell line, with overexpression of NOTCH2 and HEY1.
• ABCB1 was highly overexpressed in both MDR cell lines, and its promoter was unmethylated in both.

Conclusions:

• Transcriptional profiling effectively identified genetic alterations associated with multidrug resistance in cancer cell lines.
• Overexpression of ABCB1, coupled with an unmethylated promoter, is a key characteristic of these MDR cell lines.
• The NOTCH pathway may play a role in the development of multidrug resistance, warranting further investigation.